[ET Net News Agency, 24 August 2021] Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
(02196) said its profit attributable to owners of the parent was RMB2.48 billion for the
six months ended 30 June 2021, a year-on-year increase of 44.77%. Basic earnings per share
were RMB0.97. No dividend will be distributed.
Revenue was RMB16.88 billion, a year-on-year increase of 20.85%. (RC)